TIMELINE
On November 7th, the first global Urolithin A Scientific Summit, brought to the world stage by Timeline, is set to present paradigm-shifting research in the field of longevity. Led by experts in the scientific community, the virtual summit, open to the general public, practitioners, and scientists, will highlight the latest research in aging, particularly focusing on Urolithin A—a breakthrough postbiotic natural molecule with a meaningful impact on health.
The summit will explore the latest science around Urolithin A, featuring an impressive lineup of distinguished researchers and clinicians including, Prof. Johan Auwerx, MD PhD (Swiss Federal Technology Institute EPFL); Prof. Brian Kennedy, PhD (National University of Singapore); Prof. Eric Verdin, MD PhD (President of the Buck Institute for Research on Aging); Prof. Coleen Murphy, PhD (Princeton University); Prof. Navindra Seeram, PhD (University of Rhode Island); Dr. Dominic Denk, MD (Goethe-University Hospital Frankfurt); Dr. Nicola Vannini (University of Lausanne/Ludvig Cancer Institute), Prof. Evandro Fang, PhD (Oslo University) and many more.
Urolithin A stands at the forefront of healthy aging with its unique potential to target several of the most important hallmarks of aging. Timeline has invested over 15 years of pioneering work in longevity research that has been instrumental in making this molecule accessible to people as a safe and effective health product. The daylong event will feature topics grounded in science and rooted in mitochondrial health, like:
- Mitophagy, Biological Aging, Natural Origins of Urolithin A
- Insulin Sensitivity, Metabolic Disease, Diabetic Kidney Disease
- Brain Aging & Alzheimer’s, Immune System, Antitumor Immunity
- Skin Health, Longevity Interventions, Heart Health and Athletic Performance and Recovery
“We are thrilled to inaugurate this groundbreaking summit, uniting brilliant minds to explore Urolithin A’s potential and further innovations that can promote healthspan” said Chris Rinsch, Ph.D., President and Co-founder of Timeline. “Timeline has always been at the cutting edge and this event marks a significant milestone in our journey of raising the bar in longevity, nutrition and skin health science.”
Learn more about the all-day virtual summit and register at https://www.timelinenutrition.com/promotions/1st-urolithin-a-summit
About Timeline
Timeline® is brand of Amazentis, a pioneering health science company committed to revolutionizing the longevity industry with its groundbreaking, clinically proven, proprietary ingredient Mitopure® (Urolithin A). With a strong foundation in bioscience research, Timeline® seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. For more information, visit www.timelinenutrition.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231103248653/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H2SITE Secures EIC Accelerator Funding to Deploy a Flagship 1 TPD Ammonia Cracker Using Membrane Reactor Technology at a Port in North-West Europe3.7.2025 08:40:00 CEST | Press release
H2SITE has been awarded the EIC (European Innovation Council) Accelerator program for a project aimed at deploying a first-of-its-kind ammonia cracking unit capable of producing 1 ton of high-purity hydrogen per day. The system is based on H2SITE’s proprietary palladium-based membrane reactor technology, which enables the simultaneous catalytic decomposition of ammonia and selective hydrogen separation within a single unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702142283/en/ Ammonia Cracker using Membrane Reactor Technology This breakthrough technology offers several compelling advantages over conventional ammonia cracking processes: Lowest Levelized Cost of Hydrogen (LCOH) from ammonia due to high efficiency and integrated operation Reduced energy consumption, operating at significantly lower temperatures (400–450 °C) than traditional cracking methods (typically 600–800 °C) High-purity hydrogen output, compliant
Curve Pay and Thales Join Forces to Securely Transform Digital Wallets on iPhone3.7.2025 08:00:00 CEST | Press release
This collaboration between Curve and Thales provides iOS users with greater control, flexibility, autonomy and digital-security for in-store contactless payments and digital wallets Curve, the ultimate digital wallet, today announced deepening its collaboration with Thales, the global leader in advanced technologies, delivering secure modern payment solutions for financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702696837/en/ Thales D1 Platform to power CURVE PAY (Photo: Thales) This partnership comes on the back of Curve launching Curve Pay on iOS, marking a watershed moment in mobile payments. This partnership is a significant step to reshaping everyday spending, allowing Curve customers to benefit from NFC payment directly in the Curve App for contactless payments in store for all end-users on iOS and Android. Curve Pay is underpinned by Thales’ D1 platform on iOS and Android in Europe which allows
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment3.7.2025 08:00:00 CEST | Press release
New TBS Osteo Advanced next-generation software enhances fracture risk detection beyond standard of care in osteoporosis, a silent disease affecting over 32 million Europeans1 TBS Osteo Advanced next-generation software to be rolled-out across Europe Broad clinical adoption reinforces TBS Osteo leadership in bone microarchitecture evaluation for fracture risk assessment Subscription-based model offers ongoing services and access to future clinical innovations Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, announces the European launch of its MDR-cleared next-generation TBS Osteo Advanced software. Following the product launch in the United States last month, this next milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702082335/en/ Medimaps' TBS Osteo next-generatio
ISDA and Ant International Lead New Industry Report on Use of Tokenised Bank Liabilities for FX Settlement and Cross-Border Payments Under Project Guardian3.7.2025 08:00:00 CEST | Press release
Report builds on shared ledger technology and industry expertise of the co-leads as well as members of the Project Guardian FX workstreamIt includes proposed principles for leveraging tokenised bank liabilities and shared ledgers to drive industry adoption of tokenisation and enable 24/7, real-time FX settlement and lower costs for businesses globally The International Swaps and Derivatives Association (ISDA) and Ant International led the Project Guardian FX industry group to develop a new report for implementing tokenised bank liabilities and shared ledger in cross-border payments and foreign exchange (FX) settlement. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702791535/en/ Report on Use of Tokenised Bank Liabilities for Transaction Banking by ISDA and Ant International, under the Monetary Authority of Singapore's (MAS) Project Guardian The joint report is produced under the Monetary Authority of Singapore's (MAS) Pr
Year-old European startup Maisa named alongside Google and Amazon in elite list of leading AI agent vendors in top global US research reports by Gartner3.7.2025 01:01:00 CEST | Press release
- First time a Spanish startup has made the list, thanks to its industry-first hallucination resistant ‘digital workers’ - AI startup is one of two European AI agent vendors in Gartner’s Hype Cycle report for Artificial Intelligence and Hype Cycle for the Future of Work lists Maisa, a rising star of enterprise AI, has been named by leading global research and advisory firm Gartner in its list of leading vendors for developing reliable AI agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702640749/en/ Maisa founders David Villalón and Manuel Romero Inclusion in Gartner’s 2025 Hype Cycle for AI and Hype Cycle for the Future of Work marks the first time a Spanish startup has been mentioned in these influential reports. The company, which is barely a year old and made its first raise of $5m+ from leading US investors last year, now finds itself named alongside global giants Amazon Web Services, Google, Salesforce and Lan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom